Plingor

Brain Advance Access published January 4, 2008 doi:10.1093/brain/awm313 Brain (2007) Page 1 of 12 Attentional control in Parkinson’s disease is dependent on COMTval158met genotype Caroline H. Williams-Gray,1 Adam Hampshire,2 Roger A. Barker1,Ã and Adrian M. Owen2,Ã 1 Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge and 2MRC Cognition and Brain...

7272 • The Journal of Neuroscience, July 5, 2006 • 26(27):7272–7280 Neurobiology of Disease Dopamine D3 Receptor Agonist Delivery to a Model of Parkinson’s Disease Restores the Nigrostriatal Pathway and Improves Locomotor Behavior Jackalina M. Van Kampen and Christopher B. Eckman Departments of Pharmacology and Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224 The pr...

Brain Research 1023 (2004) 83 – 91 www.elsevier.com/locate/brainres Research report Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra Davor Stanica,1, Wanida Tripanichkula,1, John Dragob, David I. Finkelsteinb, Malcolm K. Horneb,* b a Department of Medicine, Monash University, Monash Medical Centre, Block E, Level 5, 246 Clayton ...

European Journal of Neuroscience, Vol. 18, pp. 1175±1188, 2003 ß Federation of European Neuroscience Societies Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat D. Stanic,1,Ã D. I. Finkelstein,1,2,Ã D. W. Bourke,1 J. Drago1,2 and M. K. Horne1,2 1 2 Department of Medicine, Monash University, Monash Medical Centre, Clayton, Australia Howard Florey ...

Movement Disorders Vol. 21, No. 2, 2006, pp. 136 –141 © 2006 Movement Disorder Society Viewpoint Crossroads in GDNF Therapy for Parkinson’s Disease Todd B. Sherer, PhD,1* Brian K. Fiske, PhD,1 Clive N. Svendsen, PhD,2 Anthony E. Lang, MD, FRCP,3 and J. William Langston, MD4 Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA 2 Waisman Center, University of Wisconsin, M...

www.elsevier.com/locate/ynbdi Neurobiology of Disease 25 (2007) 35 – 44 Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism Yotam Sagi, Silvia Mandel, Tamar Amit, and Moussa B.H. Youdim⁎ Eve Topf and USA National Parkinson Foundation, Centers of Excellence for Neurodeg...

European Journal of Neuroscience, Vol. 24, pp. 361–370, 2006 doi:10.1111/j.1460-9568.2006.04919.x Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson’s disease M. McLeod, M. Hong, K. Mukhida, D. Sadi, R. Ulalia and I. Mendez Cell Restoration Laboratory, Brain Repair Centre, 12th floor, ...

Journal of Neuroscience Research 85:536–547 (2007) Regeneration of Nigrostriatal Dopaminergic Axons by Degradation of Chondroitin Sulfate Is Accompanied by Elimination of the Fibrotic Scar and Glia Limitans in the Lesion Site Hong-Peng Li,1,2 Akiko Homma,1 Kazunori Sango,1 Koki Kawamura,1 Geoffrey Raisman,3 and Hitoshi Kawano1* Department of Developmental Morphology, Tokyo Metropolitan Institu...

Journal of Neuroscience Research 85:536–547 (2007) Regeneration of Nigrostriatal Dopaminergic Axons by Degradation of Chondroitin Sulfate Is Accompanied by Elimination of the Fibrotic Scar and Glia Limitans in the Lesion Site Hong-Peng Li,1,2 Akiko Homma,1 Kazunori Sango,1 Koki Kawamura,1 Geoffrey Raisman,3 and Hitoshi Kawano1* Department of Developmental Morphology, Tokyo Metropolitan Institu...

ORIGINAL ARTICLES Randomized Controlled Trial of Intraputamenal Glial Cell Line–Derived Neurotrophic Factor Infusion in Parkinson Disease Anthony E. Lang, MD,1 Steven Gill, MD,2 Nik K. Patel, MD,2 Andres Lozano, MD,3 John G. Nutt, MD,4 Richard Penn, MD,5 David J. Brooks, MD,6 Gary Hotton, MD,6 Elena Moro, MD,1 Peter Heywood, MD,1 Matthew A. Brodsky, MD,4 Kim Burchiel, MD,4 Patrick Kelly, MD,7 ...